We are live on !
Find out more
2Xideas Portfolio holdings
AUM
$232M
Turnover
6.12%
1-Year Est. Return
4.22%
This Fund
S&P 500
This Quarter Est. Return
+8.51%
1 Year Est. Return
+4.22%
3 Year Est. Return
+40.58%
5 Year Est. Return
+44.98%
10 Year Est. Return
–
AUM
$581M
AUM Growth
-$77.3M
(-12%)
Cap. Flow
-$111M
Cap. Flow % of AUM
Cap. Flow %
-19.11%
Top 10 Holdings %
Top 10 Hldgs %
48.72%
Holding
63
New
2
Increased
11
Reduced
44
Closed
6
Avg Time Held
2.6
years
Top 10 Avg Time Held
1.7
years
Top 20 Avg Time Held
1.7
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Edwards Lifesciences
EW
|
+$24.6M |
| 2 |
OS
OneStream Inc
OS
|
+$4.35M |
| 3 |
nVent Electric
NVT
|
+$3.7M |
| 4 |
Tyler Technologies
TYL
|
+$1.74M |
| 5 |
Ryan Specialty Holdings
RYAN
|
+$1.46M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
IQVIA
IQV
|
+$21.3M |
| 2 |
Ares Management
ARES
|
+$8.99M |
| 3 |
Fortinet
FTNT
|
+$7.01M |
| 4 |
Intuit
INTU
|
+$6.96M |
| 5 |
Teradyne
TER
|
+$6.94M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 31.78% |
| 2 | Healthcare | 24.57% |
| 3 | Financials | 20.71% |
| 4 | Industrials | 11.59% |
| 5 | Consumer Discretionary | 5.95% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
1
Intercontinental Exchange
ICE
$99.4B
| $51.8M | 8.91% |
282,187
-35,177
| -11% | -$6.04M |
2020 Q4
18 quarters
|
|
|
2
Fortinet
FTNT
$95.2B
| $51.3M | 8.83% |
485,213
-69,456
| -13% | -$7.01M |
2020 Q4
18 quarters
|
|
3
PTC
PTC
$21.3B
| $45.7M | 7.86% |
264,951
-11,625
| -4% | -$1.87M |
2022 Q3
11 quarters
|
|
|
4
Edwards Lifesciences
EW
$60.8B
| $40.7M | 7.01% |
520,711
+330,127
| +173% | +$24.6M |
2020 Q4
18 quarters
|
|
5
ResMed
RMD
$33.6B
| $19.4M | 3.34% |
75,214
-4,108
| -5% | -$980K |
2020 Q4
18 quarters
|
|
6
Ferguson
FERG
$49.3B
| $17.6M | 3.04% |
81,005
-16,501
| -17% | -$3.04M |
2024 Q3
3 quarters
|
|
7
Autodesk
ADSK
$54.2B
| $16.9M | 2.91% |
54,679
-9,426
| -15% | -$2.67M |
2024 Q2
4 quarters
|
|
|
8
Ryan Specialty Holdings
RYAN
$5.52B
| $13.7M | 2.36% |
201,819
+21,161
| +12% | +$1.46M |
2024 Q1
5 quarters
|
|
9
Kinsale Capital Group
KNSL
$8.78B
| $12.9M | 2.22% |
26,665
-4,755
| -15% | -$2.22M |
2021 Q3
15 quarters
|
|
10
CoStar Group
CSGP
$12.1B
| $12.9M | 2.22% |
160,167
-15,462
| -9% | -$1.2M |
2020 Q4
18 quarters
|
|
11
DexCom
DXCM
$30.4B
| $12.6M | 2.17% |
144,099
-27,564
| -16% | -$2.16M |
2025 Q1
1 quarter
|
|
12
Planet Fitness
PLNT
$4.47B
| $12.3M | 2.12% |
112,894
-13,488
| -11% | -$1.35M |
2024 Q4
2 quarters
|
|
13
Gartner
IT
$12B
| $11M | 1.89% |
27,103
-2,901
| -10% | -$1.21M |
2020 Q4
18 quarters
|
|
|
14
IQVIA
IQV
$44.7B
| $9.9M | 1.71% |
62,894
-141,343
| -69% | -$21.3M |
2020 Q4
18 quarters
|
|
15
KLA
KLAC
$205B
| $9.7M | 1.67% |
108,100
-41,390
| -28% | -$3.11M |
2023 Q2
8 quarters
|
|
16
Halozyme
HALO
$11.5B
| $9.6M | 1.65% |
184,546
-62,256
| -25% | -$3.54M |
2022 Q2
12 quarters
|
|
17
Brookfield Asset Management
BAM
$82.1B
| $9.35M | 1.61% |
169,258
-17,600
| -9% | -$945K |
2023 Q4
6 quarters
|
|
18
Neurocrine Biosciences
NBIX
$17.1B
| $8.52M | 1.47% |
67,813
-4,696
| -6% | -$539K |
2024 Q4
2 quarters
|
|
19
Tradeweb Markets
TW
$27.5B
| $8.47M | 1.46% |
57,878
+3,445
| +6% | +$481K |
2020 Q4
18 quarters
|
|
20
New York Times
NYT
$11.4B
| $8.38M | 1.44% |
149,714
-67,147
| -31% | -$3.56M |
2021 Q2
16 quarters
|
|
21
CCC Intelligent Solutions
CCC
$4.55B
| $8.33M | 1.44% |
885,722
-13,089
| -1% | -$117K |
2024 Q4
2 quarters
|
|
22
MSCI
MSCI
$46.6B
| $8.01M | 1.38% |
13,895
-3,496
| -20% | -$1.93M |
2020 Q4
18 quarters
|
|
23
EXL Service
EXLS
$6.5B
| $7.5M | 1.29% |
171,163
-39,603
| -19% | -$1.81M |
2024 Q4
2 quarters
|
|
24
Labcorp
LH
$30.2B
| $7.33M | 1.26% |
27,921
-4,559
| -14% | -$1.11M |
2022 Q4
10 quarters
|
|
25
Carlisle Companies
CSL
$15.2B
| $7.3M | 1.26% |
19,549
-8,949
| -31% | -$3.32M |
2024 Q3
3 quarters
|
|
Similar funds
PC
EMB
WM
MFG
2Xideas's Q2 2025 Portfolio in Review
As of Q2 2025, 2Xideas held 63 positions worth $581M, down 12% from $658M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
2Xideas withdrew a net $111M in Q2 2025, closing 6 positions and reducing 44 holdings. Its most notable exit was Ares Management, an estimated $8.99M position sold in full.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 31% a quarter earlier, followed by Healthcare and Financials.
Against the trend, 2Xideas opened a new position in OneStream Inc worth $4.94M.
- 2Xideas's largest Q2 2025 buy was OneStream Inc: 174,621 shares worth $4.94M.
- 2Xideas added most to Edwards Lifesciences in Q2 2025, an estimated $24.6M increase.
- 2Xideas's biggest Q2 2025 reduction was IQVIA, cutting an estimated $21.3M.
- 2Xideas fully exited Ares Management in Q2 2025, selling an estimated $8.99M.
- 2Xideas's ten largest holdings make up 49% of its $581M portfolio in Q2 2025.
- 2Xideas opened 2 new positions and closed 6 in Q2 2025.
- 2Xideas's portfolio value fell 12% quarter-over-quarter to $581M.
Based on 2Xideas's 13F filing for Q2 2025, filed 14 Aug 2025.